Waverunner Capital Inc. (CHM.CN) traded at C$0.05 on the CNQ during market hours on 13 Jan 2026, making it a high-volume mover today. The jump followed a large percentage move from a prior close of C$0.01 and pushed the one-year change to +400.00%. Traders cited thin liquidity and micro-cap dynamics as drivers. We examine fundamentals, valuation, technicals, and short-term catalysts for CHM.CN stock, and outline what active traders should monitor next.

Intraday price action and volume for CHM.CN stock

CHM.CN stock registered a trade price of C$0.05 with a reported one-day change of +900.00% against the previous close of C$0.01. Volume data is sparse on public feeds, but the 50-day average price is C$0.04. Thin daily liquidity and a small float of 744,233,000 shares can create outsized moves. Watch bid-ask spreads and average volume of 28,908 for execution risk.

Fundamentals and CHM.CN earnings snapshot

Waverunner Capital operates as a venture investor across early-stage and renewables. The company reports EPS of -0.01 and a negative PE metric reflecting losses. Book value per share is -0.11 and cash per share is 0.01. The balance sheet shows tight working capital with a current ratio of 0.16, highlighting liquidity pressure for CHM.CN stock holders.

Valuation, sector context and CHM.CN analysis

In the Healthcare sector, average PE sits near 14.62. CHM.CN’s metrics diverge from peers with a negative PE and price-to-book of -0.46. Market cap stands at C$37,211,650.00. For valuation context, the stock’s enterprise value to EBITDA is negative -9.76, reflecting losses and low revenue. Investors should compare this micro-cap’s risk profile to larger healthcare names before sizing positions.

Meyka AI rates CHM.CN with a score out of 100: grade and model forecast

Meyka AI rates CHM.CN with a score of 61.15 out of 100 — Grade B, Suggestion HOLD. This grade factors S&P 500 comparison, sector performance, financial growth, key metrics, and analyst consensus. Meyka AI’s forecast model projects a short-term base case price target of C$0.07, implying +40.00% upside from C$0.05. A downside scenario targets C$0.03, implying -40.00%. Forecasts are model-based projections and not guarantees.

Risks, catalysts and CHM.CN outlook

Primary risks include thin liquidity, negative earnings, and a low current ratio of 0.16. Catalysts that could lift the stock are new PIPE financing, asset sales, or positive updates from portfolio ventures. With a year high of C$0.10 and a year low of C$0.05, short-term moves will track news and block trades more than fundamentals. Monitor company filings and press releases closely.

Trading strategy and technicals for CHM.CN stock movers

For active traders, use limit orders and keep position sizes small. The 50-day average price is C$0.04 and the 200-day average is C$0.05. Given the high volatility, a stop-loss around C$0.03 helps manage downside. Longer-term investors should wait for clearer revenue growth and improved balance-sheet ratios before adding exposure to CHM.CN stock.

Final Thoughts

CHM.CN stock is a high-volume micro-cap moving on thin liquidity and event-driven flows. The share price at C$0.05 on 13 Jan 2026 reflects volatile trading rather than a steady earnings improvement. Fundamental metrics show negative EPS of -0.01, negative book value per share of -0.11, and tight liquidity with a current ratio of 0.16. Meyka AI’s model projects a near-term base target of C$0.07, an implied upside of +40.00%, and a downside scenario to C$0.03, implying -40.00%. These model outputs are projections and not guarantees. Traders should limit size, use strict risk controls, and watch company news and any capital raises closely. For reference and filings visit the company site and public profile Waverunner Capital and the public data image from Financial Modeling Prep profile image. Meyka AI provided this AI-powered market analysis to frame short-term opportunity and risk for CHM.CN stock.

FAQs

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.